Article

DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: Psychometric validity and response to antipsychotic medication

Psychiatric Unit, Virgen del Camino Hospital, Irunlarrea 4, 31008 Pamplona, Spain.
Schizophrenia Research (Impact Factor: 4.43). 05/2010; 118(1-3):168-75. DOI: 10.1016/j.schres.2009.12.023
Source: PubMed

ABSTRACT To examine the prevalence, psychometric validity and response to antipsychotic drugs of DSM-IV catatonia signs and criteria in patients with a first-episode psychotic disorder.
Two-hundred antipsychotic-naive patients with a DSM-IV nonaffective psychosis were assessed for catatonia signs and criteria using the Modified Rogers Scale, and the psychometric validity of the 12 DSM-IV catatonia signs and diagnostic criteria was examined. Treatment response of catatonia was assessed in 173 patients who completed one-month trial with haloperidol (n=23), risperidone (n=93) or olanzapine (n=57).
Sixty-two patients (31%) endorsed at least one catatonia sign and 24 (12%) met DSM-IV criteria for catatonia. DSM-IV catatonia signs showed an excellent convergent validity (r>0.8) with other rating scales, and DSM-IV criteria showed moderate to fair concordance with other criteria (kappa from 0.57 to 0.77). The total number of signs reflected catatonia severity and demonstrated excellent diagnostic performance against alternative diagnostic criteria. The presence of at least any three signs accurately identified patients with catatonia. Three catatonia domains were identified (hyperkinesia, volitional and hypokinesia), which showed a different association pattern with external variables. Overall, catatonia ratings were particularly related to both dyskinesia and disorganization symptoms and lacked diagnostic specificity for schizophrenia. Patients with catatonia responded well to antipsychotic medication irrespective of the type of antipsychotic drug used, although treatment response was dependent upon the remission of psychotic symptoms.
These results may inform the DSM-V development on diagnosis and classification of catatonia, and indicate that catatonia signs and syndromes are highly responsive to antipsychotic drugs.

2 Followers
 · 
81 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Der zweite Teil des CME-Artikels Psychopharmaka und Psychopharmakotherapie im Notarztdienst setzt sich mit der Pharmakotherapie psychischer Störungen im Notarztdienst auseinander. Im Gegensatz zum Vorgehen bei somatischen Notfällen ist die Pharmakotherapie psychiatrischer Notfälle vielen Notfallmedizinern häufig nicht ausreichend bekannt, obwohl hierfür ebenfalls Leitlinien und Empfehlungen existieren. Im vorliegenden Beitrag werden für die 5 notfallmedizinisch relevanten Syndrome Suizidalität, Delir, psychomotorische Erregungszustände, Stupor und Dissoziation sowie psychopharmakainduzierte Syndrome die aktuellen Therapieempfehlungen, wie sie auch in der demnächst erscheinenden S2-Leitlinie Notfallpsychiatrie beschrieben werden, dargestellt. Abstract Part two of the CME article Psychotropic agents and psychopharmacotherapy in emergency medicine aims to give an understanding of the pharmacotherapy of psychiatric disorders in emergency medicine. In contrast to somatic emergencies, many emergency physicians are not familiar with the treatment of psychiatric emergencies, although there are guidelines and recommendations. In the following article, treatment recommendations for the 5 most common and relevant syndromes in emergency medicine (i.e., suicide, delirium, agitation, stupor, and syndromes due to psychopharmaceutical use) are described based on the German S2-Guideline Emergency Psychiatry that will be published soon.
    Notfall 10/2013; 16(6):477-491. DOI:10.1007/s10049-013-1701-2 · 0.32 Impact Factor
  • Source
    Schizophrenia Research 02/2014; · 4.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The classification of catatonia has fluctuated and underwent recent changes in DSM-5. The current study examines the prevalence of catatonia signs, estimates the utility of diagnostic features, identifies core catatonia signs, and explores their underlying structure.
    Schizophrenia Research 05/2015; 164(1-3). DOI:10.1016/j.schres.2014.12.036 · 4.43 Impact Factor